LRP4 and myasthenia gravis: The most common patients affected by LRP4-MG are young individuals, with a female predominance, with a mean age of onset in the early 30s for females and early 40s for males in European and Mediterranean populations, while over half of LRP4-MG cases occur in pediatric patients in Chinese cohorts [17,81].